Francesco de Rubertis, Director at Centessa Pharmaceuticals plc (CNTA), bought 135,457 shares at $11.34 ($1.6M) on 2021-11-26, disclosed to the SEC on 2021-11-30.
Open-market purchase of $1.6M CNTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.34 | 274 | $3K | 0.2% |
| 2 | $11.34 | 11,543 | $131K | 8.3% |
| 3 | $11.34 | 11,543 | $131K | 8.3% |
| 4 | $11.70 | 1,315 | $15K | 1.0% |
| 5 | $11.70 | 55,391 | $648K | 41.1% |
| 6 | $11.70 | 55,391 |
| $648K |
| 41.1% |
| Total | $11.64 avg | 135,457 | $1.6M | 100% |
| Filing → |
| CNTA | BUY | 2021-06-04 | $12.0M | — | Filing → |
| NERV | SELL | 2016-08-12 | $10.0M | — | Filing → |
| NERV | BUY | 2015-03-20 | $975K | — | Filing → |